- Level
- Postgraduate
- Duration
- Full Time, 1 Years; Part Time, 2 Years
- Mode
- Part-time
- Subject
- Medicine
- Location
- United Kingdom
Overview
Teaching Excellence: You will be taught by Internationally renowned researchers who support with research projects in Cancer Immunotherapy. Employment Prospects: Graduates work as research scientists, scientific officers, and senior managers for organisations including Roche, Merck, and Astra Zeneca. Sector-led Course Content: Explore our research interests of the Bioscience Research Group covering topics such as Adoptive T cell therapy, tumour-associated macrophages, NK cells, and monoclonal antibodies in cancer therapy.
Entry requirements
| Degree | 2nd class · Subjects: disciplines · or above |
|---|
English language requirements
| IELTS | 6.0 overall, no part below 5.5 |
|---|
IELTS score of 6.0 with a minimum of 5.5 in each band.
Fees
International students: £17,950
UK students: £11,310
UK/Home: £11,310
International: £17,950
Start dates
September
Application deadline
No fixed deadline; apply via the course page
Campus
- University of Hertfordshire, Hatfield, United Kingdom